The standard clinical approach is to continue your current metformin dose while introducing semaglutide at a low starting dose, then titrating semaglutide upward over weeks according to your individual tolerance and response
S., Hobaus, J
Safety and Clinical Considerations Gastrointestinal adverse effects The most common adverse effects of incretin-based therapies are gastrointestinal, including nausea, vomiting, diarrhea, constipation, dyspepsia, and abdominal discomfort
And the mechanism of how these molecules are taken up remains to be fully explained
What Happens When You Dont Eat Enough When youre on a GLP-1 medication, your appetite naturally decreases, and thats part of how it works
Orders suspected of being for resale purposes may be canceled at our discretion